Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00687232 | Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers | PHASE1 | COMPLETED | 30 | — | — | Jan 1, 2008 | May 1, 2008 | Dec 1, 2010 | 1 | Japan |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | AZD4818 |
| 2 | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| AZD4818 | DRUG | Dry powder, inhalation, b.i.d, 10 + 1/2 days or 20 + 1/2 days |
| Placebo | DRUG | - |
Inclusion Criteria: * Provision of informed consent * Body Mass Index (BMI) between 18.0-27.0 kg/m2 * No clinically relevant abnormal findings Exclusion Criteria: * Acute illness which requires medical intervention * Definite or suspected personal history of adverse drug reactions or drug hyperse...